Cargando…
Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response
Clostridium difficile infection (CDI) is a major public health threat worldwide. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with enhanced susceptibility to and severity of CDI; however, the mechanisms driving this phenomenon have not been elucidated. NSAIDs alter prostagl...
Autores principales: | Maseda, Damian, Zackular, Joseph P., Trindade, Bruno, Kirk, Leslie, Roxas, Jennifer Lising, Rogers, Lisa M., Washington, Mary K., Du, Liping, Koyama, Tatsuki, Viswanathan, V. K., Vedantam, Gayatri, Schloss, Patrick D., Crofford, Leslie J., Skaar, Eric P., Aronoff, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325247/ https://www.ncbi.nlm.nih.gov/pubmed/30622186 http://dx.doi.org/10.1128/mBio.02282-18 |
Ejemplares similares
-
Reply to Noori et al., “A Complex Scenario of Nonsteroidal Anti-inflammatory Drugs Induced Prostaglandin E2 Production and Gut Microbiota Alteration in Clostridium difficile-Infected Mice”
por: Maseda, Damian, et al.
Publicado: (2020) -
Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to Clostridioides difficile toxin–mediated mitochondrial damage
por: Soto Ocaña, Joshua, et al.
Publicado: (2023) -
An Engineered Synthetic Biologic Protects Against Clostridium difficile Infection
por: Vedantam, Gayatri, et al.
Publicado: (2018) -
Phylogenomic analysis of Clostridioides difficile ribotype 106 strains reveals novel genetic islands and emergent phenotypes
por: Roxas, Bryan Angelo P., et al.
Publicado: (2020) -
Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile
por: Merrigan, Michelle M., et al.
Publicado: (2013)